# QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct07110064/  
OnCo record `nct07110064` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of iparomlimab and tuvonralimab, lenvatinib and gemcitabine + nab-paclitaxel in pancreatic cancer, run by Du Juan, now recruiting.

## Summary

QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT07110064 by Du Juan, with a registry enrolment figure of 80 participants, started 2025-09-03 and due to reach its primary completion in 2027-08-31. Interventions recorded: QL1706+Lenvatinib+AG Regimen. Conditions listed: Advance Pancreatic Cancer. Primary outcome: Median Progression-Free Survival (mPFS). Pancreatic eligibility wording from the registry: "Patients with histologically or cytologically confirmed advanced metastatic pancreatic cancer". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07110064
- Phase: 2
- Setting: Iparomlimab and Tuvonralimab Injection (QL1706) in Combination With Lenvatinib and AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer:A Prospective, Single-Arm, Multicenter, Phase II Clinical Study
- Sponsor: Du Juan
- Enrolled: 80

## Sources

- ClinicalTrials.gov NCT07110064: https://clinicaltrials.gov/study/NCT07110064

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine + nab-paclitaxel](https://onco.cc/drugs/gemcitabine-nab-paclitaxel/), [Iparomlimab and tuvonralimab](https://onco.cc/drugs/iparomlimab-tuvonralimab/), [Lenvatinib](https://onco.cc/drugs/lenvatinib/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07110064.json